Systemic lupus erythematosus (SLE) is a multi-system, chronic, rare orphan disease that impacts physical and psychological functioning. It is a complex autoimmune disorder with much greater prevalence among women than men. The course of the disease varies in subpopulations, with ethnic/racial minority women most severely impacted. Mental health professionals providing services to patients with SLE use an eclectic multi-method approach in treatment and evaluation. Psychoeducational and psychotherapeutic interventions are required due to the variability in SLE symptoms and the serious complications of the disease.
This course is designed for social workers, counselors, therapists, and mental health staff involved in the care of patients with systemic lupus erythematosus.
NetCE has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6361. Programs that do not qualify for NBCC credit are clearly identified. NetCE is solely responsible for all aspects of the programs. NetCE, #1092, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org through the Approved Continuing Education (ACE) Program. NetCE maintains responsibility for the program. ASWB Approval Period: 03/13/2016 to 03/13/2019. Social workers should contact their regulatory board to determine course approval for continuing education credits. NetCE SW CPE is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #0033. This course is considered self-study, as defined by the New York State Board for Social Work. This course is approved by the Association of Social Work Boards - ASWB NJ CE Course Approval Program Provider #14 Course #741. Social workers will receive the following type and number of credit(s): General Social Work Practice 2 for the approval period starting 09/27/2016 and ending 09/27/2018. Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of licensed master social work and licensed clinical social work in New York. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice for an LMSW and LCSW. A licensee who practices beyond the authorized scope of practice could be charged with unprofessional conduct under the Education Law and Regents Rules.
NetCE designates this continuing education activity for 0.5 NBCC clock hour(s). Social workers participating in this intermediate to advanced course will receive 2 Clinical continuing education clock hours, in accordance with the Association of Social Work Boards.
In addition to states that accept ASWB, NetCE is approved as a provider of continuing education by the following state boards: Alabama State Board of Social Work Examiners, Provider #0515; Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling, CE Broker Provider #50-2405; Illinois Division of Professional Regulation for Social Workers, License #159.001094; Illinois Division of Professional Regulation for Licensed Professional and Clinical Counselors, License #197.000185; Illinois Division of Professional Regulation for Marriage and Family Therapists, License #168.000190; Texas State Board of Social Worker Examiners, Approval #3011; Texas State Board of Examiners of Professional Counselors, Approval #1121; Texas State Board of Examiners of Marriage and Family Therapists, Approval #425.
The purpose of this course is to provide mental health professionals with the tools necessary to effectively address the psychosocial needs of patients with SLE.
Upon completion of this course, you should be able to:
- Outline the epidemiology and pathophysiology of systemic lupus erythematosus (SLE).
- Discuss the diagnosis and medical treatment of SLE.
- Identify components of the psychological evaluation of patients with SLE.
- Describe how to select the appropriate psychological services and treatment plan for patients with SLE, taking into account potential comorbid psychiatric disorders.
Kathleen Holland, PsyD, is a California-licensed psychologist, credentialed school psychologist and licensed educational psychologist, currently in private practice in Sebastopol, California. She obtained a Master’s degree in psychology from San Jose State University and a PsyD from Newport University. Dr. Holland is a member of the American Psychological Association, the American College of Forensic Examiners, and the American College of Forensic Psychologists. She has written and presented extensively in the areas of psychological evaluation and the provision of psychological services to a variety of patient populations.
Contributing faculty, Kathleen Holland, PsyD, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
Alice Yick Flanagan, PhD, MSW
The division planner has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
The purpose of NetCE is to provide challenging curricula to assist healthcare professionals to raise their levels of expertise while fulfilling their continuing education requirements, thereby improving the quality of healthcare.
Our contributing faculty members have taken care to ensure that the information and recommendations are accurate and compatible with the standards generally accepted at the time of publication. The publisher disclaims any liability, loss or damage incurred as a consequence, directly or indirectly, of the use and application of any of the contents. Participants are cautioned about the potential risk of using limited knowledge when integrating new techniques into practice.
It is the policy of NetCE not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Supported browsers for Windows include Microsoft Internet Explorer 9.0 and up, Mozilla Firefox 3.0 and up, Opera 9.0 and up, and Google Chrome. Supported browsers for Macintosh include Safari, Mozilla Firefox 3.0 and up, Opera 9.0 and up, and Google Chrome. Other operating systems and browsers that include complete implementations of ECMAScript edition 3 and CSS 2.0 may work, but are not supported.
#76040: Psychological Services for Patients with Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a rare, multi-system, chronic disease that impacts physical and psychological functioning . This complex autoimmune disorder affects more women than men and is more common among racial/ethnic minorities (e.g., African Americans, Hispanic women) than non-Hispanic white populations . Manifestations of the disease can vary widely and include organ-threatening complications, fatigue, stress, depression, anxiety, and pain . Research has identified specific mental health needs in the SLE population, and mental health professionals providing services to patients with SLE use an eclectic, multi-method approach in the treatment and evaluation of these individuals. Both psychoeducational and psychotherapeutic interventions are required due to the variability of SLE symptoms and the serious complications of this disease. Interventions and therapy should be targeted and sensitive.
Patients with SLE face a cycle of stress and frustration due to the changes in their physical health, their appearance, and their lifestyle that occur as a result of the disease . SLE is an inflammatory autoimmune disorder in which the immune system produces autoantibodies that attack healthy cells, causing inflammation and other complications that can impair organs and systems, including the kidney, skin, blood, and central nervous system (CNS) . As noted, symptoms may include depression, anxiety, impaired joint mobility (and associated movement difficulties), joint pain, vision changes, low-grade fevers, photosensitivity, fatigue/malaise, sleep disturbances, and psychological distress . Stress exacerbates the symptoms of this chronic medical disorder, and symptoms often follow a course of flares and remissions.
Psychological problems may arise at different points in the course of the disease. For example, adjustment reactions are common at the initial diagnosis, while issues related to stress and pain management are ongoing . Psychological services and treatments vary in response to the needs of the individual patient, fluctuations in the disease, stage of the disease, and the debilitating aspects of the disorder .
The patient with SLE may also deal with changes in self-image, body image, and self-esteem as a result of the outward signs of the disease, including hair loss, weight gain, and facial rashes. Changes in social relationships may occur, as it can be difficult to plan social activities due to the unpredictable flare-ups and decreased functional abilities. Family relationships can be strained if expectations are not met, and work activity and recreational pursuits may suffer. Cognitive deficits can develop at any point during the course of the disease if there is CNS involvement .
It is believed that there are approximately 1.5 million individuals with lupus in the United States [4,5]. Lupus is more common than other better-known disorders, such as leukemia, multiple sclerosis, cystic fibrosis, and muscular dystrophy, affecting more individuals than all of these diseases combined .
Lupus is a significant cause of disability in the United States. According to one literature review, up to 51% of lupus patients are unable to work due to their disease and approximately 20% to 32% of patients receive disability benefits .
More than 90% of SLE cases occur in women, with most individuals developing symptoms in their childbearing years (15 to 45 years of age) . New diagnoses of lupus in women older than 45 years of age are uncommon . SLE is most common among African Americans, with African American women having three times the incidence of white American women . The incidence of lupus is also greater in Hispanic, Asian, and Native American women when compared to white women . Statistics show that black and Hispanic women tend to develop the disease at a younger age, are more likely to develop more serious complications (particularly cardiovascular complications and kidney disease), and tend to have a higher mortality rate from the disease as compared to white women .
The exact cause of lupus remains a mystery, but researchers believe that it results from multiple factors [1,9]. Possible causes may be interrelated and include immunologic dysfunction, genetic factors, hormones, and environmental influences [10,11]. The diagnosis of lupus may be a challenge for the healthcare provider as well as the patient. A diagnosis of lupus can only be made when an individual shows clinical evidence of multiple organ system disease . It is not uncommon for patients with lupus to have consulted with three to five physicians before a definitive diagnosis of lupus is given . As stated previously, an average delay of two to three years from the onset of symptoms to the time of diagnosis is common . In addition, lupus patients may have a variety of healthcare professionals caring for them due to multiple organ system involvement and a wide range of symptoms. This may result in confusion and information gaps for the patient and healthcare providers .
The antinuclear antibody (ANA) test is the most specific and sensitive test for lupus and is therefore the most commonly used autoantibody test. Ninety-seven percent of lupus patients have a positive ANA blood test. The American College of Rheumatology has developed eleven specific criteria for the diagnosis of lupus (Table 1). The individual must have four or more of the criteria present at some point during the course of their disease to be diagnosed with lupus.
AMERICAN COLLEGE OF RHEUMATOLOGY CRITERIA FOR THE DIAGNOSIS OF SLE
A combination of four or more of the following 11 criteria in a patient's history indicates a diagnosis of SLE:
Four different forms of lupus have been identified: cutaneous lupus erythematosus (CLE), drug-induced lupus, neonatal lupus, and SLE . CLE mainly affects the skin. It is associated with chronic skin eruptions that, if left untreated, can lead to scarring and permanent disfigurement. Drug-induced lupus is associated with ingestion of various drugs that result in lupus-like symptoms. Neonatal lupus is a rare, non-systemic condition affecting infants of women with lupus; symptoms typically resolve within six months. SLE, which affects multiple organ systems as well as the skin, is considered the most common of the four forms.
The medical treatment of SLE includes a variety of drug interventions to address the many manifestations of the disease, including anticoagulants, anti-inflammatory medications (including nonsteroidal anti-inflammatory drugs [NSAIDs]), glucocorticoids, antimalarials, and immunomodulating drugs . Side effects that may arise as a result of any of these medications, particularly long-term use, are a significant consideration for these patients . In cases of severe lupus kidney disease not helped by pharmacological intervention, dialysis or kidney transplant may be necessary.
Koposi was the first to identify the mental changes associated with SLE in 1875 . It has been estimated that 65% of patients with SLE have evidence of cognitive impairment and/or personality changes . Research has been limited on cognitive changes in patients with SLE due to the small sample sizes, so generalization should be guarded.
Health psychologists, neuropsychologists, and psychiatrists evaluating patients with SLE may find that they present as timid, depressed, and/or dependent. Patients may show signs of cognitive confusion, difficulty expressing oneself, and/or memory problems . Administering a mental status exam at each session is essential, as changing disease activity levels are associated with fluctuating psychological symptoms.
Get plenty of physical and emotional rest.
Maintain a healthy diet.
Establish an exercise regimen.
Seek prompt treatment of infection.
Set realistic goals and priorities.
Maintain effective communication with their healthcare providers.
Develop a support system, including family, friends, healthcare professionals, community organizations, and organized support groups.
Avoid triggering or aggravating factors.
Seek regular health care.
Eight to 10 hours of sleep per night along with naps are recommended for lupus patients. In addition, individuals with lupus should minimize stress to reduce emotional distress, as well as avoid direct prolonged sunlight, especially during the hours of 10 a.m. and 4 p.m. The use of a sunscreen with a sun protective factor (SPF) of 15 or greater that protects against both ultraviolet A and B rays is recommended along with protective clothing such as long sleeves and a hat . Routine exercise is important to reduce fatigue and maintain joint mobility.
Conducting mental health evaluations of patients with SLE is complicated by the varied symptoms and episodic nature of the disease and its impact on major life functions. A number of domains in life are affected by the disease, and throughout its course, SLE can impact a patient's psychological functioning due to socioemotional issues, economic loss, and cognitive changes .
When conducting a comprehensive psychological or psychiatric evaluation of patients with SLE, it is essential that premorbid cognitive abilities and personality styles and types are determined. Assessments should include a structured interview, observations, review of medical record, educational history, social history, occupational history, determination of the patients spiritual or religious beliefs, review of prior psychologic or psychiatric assessments, the Systemic Lupus Erythematosus Needs Questionnaire (SLENQ), cognitive evaluations, personality assessments, mental health evaluations, and medical imaging (e.g., magnetic resonance imaging) or other scans, as needed. If cognitive test measures are administered, the tools should be sensitive and specific.
The first step of assessing cognitive level of functioning is determining if the patient is medically stable by evaluating disease activity and identifying recent and current complications. As noted, cognitive impairment test scores will fluctuate as a result of natural variations in the disease process, especially if CNS involvement has been detected .
Research indicates cognitive dysfunction is not a significant factor in SLE (except with CNS involvement), and cognitive dysfunction is not consistent with or explained by a psychiatric disorder . However, the 40% of patients with SLE who do have CNS involvement are at increased risk for a variety of neurologic and psychiatric abnormalities, including seizures, stroke, psychosis, depression, and even suicide.
In the interpretation of assessment results, the examiner should determine if the findings are the result of true cognitive impairment or if other factors are affecting assessment results. Many factors can influence the results of psychological evaluations, including :
Complications of the disease
Recent organ transplant
Resilience to stress
As noted, it is important to parcel out the premorbid level of functioning, disease impact, and stability of the disease to determine if patients with cognitive deficits related to SLE would benefit from the clinical application of the modifiability model for neuropsychology rehabilitation. The neural plasticity mechanisms and the model for neuropsychological interventions and rehabilitation programs may be applicable depending on the deficits identified, the level of disease activity, and stage of the disorder.
A variety of health and behavioral interventions may be used in the treatment of patients with SLE, and practitioners will benefit from the use of a multi-method, eclectic, theoretical approach . It is important to adjust theoretic practices and borrow from both Eastern and Western theories in order to address the symptoms and stages of SLE. Approaches that have been successfully used in the treatment of patients with SLE include:
Psychoanalytic, behavioral, patient-centered therapies
Cognitive-behavioral therapy (CBT)
Emotionally focused therapies
Spiritually based therapies
Traditional psychoeducational interventions
Following a careful interpretation of the psychological evaluations, a treatment plan is developed. Treatment may include group therapy, individual or family therapy, and/or psychological interventions. As always, therapy should be targeted and sensitive, taking into consideration unmet needs and the impact of the disease on the patient's social, emotional, and physical functioning . Patients with SLE may benefit from a combination of stress and pain management techniques; therapy for adjustment reactions; CBT or other evidence-based treatments for depression, anxiety, and poor self-image; treatment for sleep disturbance; mindfulness training; guided imagery; breathing exercises; relaxation training; and/or exercise therapy.
Considerable emotional support may be required to help patients with lupus to cope with the chronic disease. More than 50% of all individuals with lupus experience emotional problems secondary to their illness . Darner found that women with lupus who had been diagnosed for longer periods of time had a healthier psychosocial adjustment . Therefore, those newly diagnosed with lupus may require more support and interventions to aid in psychosocial adjustment. Some individuals are overwhelmed with having a disease and may find professional counseling to be an important means of managing their condition.
Cognitive mapping has been used to ascertain how women with lupus represent their illness . In one study, 20 female lupus patients were interviewed in a convenience sample and asked to generate major concepts for the question, "When you think of living with lupus, what words come to mind?" In addition, participants determined the positive and negative relationship among the identified words or phrases. The concept mapping procedure generated 192 unduplicated concepts. Pain was the most commonly identified concept reported by participants. The report concluded that "although diagnosed with the same illness, women presented with different mental representations of the illness" .
Findings indicate that "support groups, self-help groups, and peer counseling…may facilitate the individual's achievement of a positive adjustment to the newly diagnosed illness" . Self-help groups offer patient education on lupus disease management, and it is recommended that those newly diagnosed with lupus receive support via peer groups. It has been noted that "participating in a support group can provide emotional assistance, boost self-esteem and morale, and help to develop or improve coping skills" . Successful support groups can assist patients to gain insights into how to live with their lupus . Support groups provide an avenue for the exchange of feelings and ideas regarding lupus. Robert Phillips, founder of the Center for Coping, stated "self-help or support groups can be incredibly helpful and are some of the best sources of support for people with lupus" . Support groups also restore a sense of autonomy and self-reliance, resulting in a reduction in dependency for the group participants . These groups can provide ideas on how to effectively cope with serious illness and manage problems associated with the condition. Lupus support groups can help members "realize they have the inner strength to cope with existential dilemmas of life as well as the comfort of knowing there are others like themselves" . Gartner states that "in the case of most chronic illnesses, the issue is care not cure, and the mutual-support group can play a powerful role in helping individuals cope with their illness" .
Online social support groups may be an important resource for lupus patients, especially those who live in rural areas or are unable to leave their homes. Patients may be directed to one of many support groups available online, including The Us in Lupus (http://www.usinlupus.com) or We Have Lupus (http://forum.wehavelupus.com).
Referral for specialized care is indicated if patients have evidence of CNS involvement, pain, persistent sleep disturbances, or other complicated issues related to physical or psychological symptoms. A multidisciplinary approach, with close collaboration among the patient's physician, mental health providers, occupational therapist, and other team members, may improve outcomes.
Research indicates that patients with SLE do not always report their needs to their health or mental health care providers . In a sample of 112 subjects with SLE who completed the SLENQ, all subjects reported at least one unmet need . African American participants reported a greater number of unmet needs related to health services and information compared with their white counterparts, and older patients experienced more unmet needs related to physical and psychological functioning than younger patients. In total, 98% of the patients had at least one unmet need related to physical health and functioning, most commonly fatigue (90.2%). Psychological and existential needs were reported by 91% of the subjects, and the most common psychological/existential needs were related to :
Fear of flare-ups (80%)
Coping with anxiety or stress (79%)
Decreased functional and social ability (77%)
Fear of physical disability (74%)
In a separate study, patients who had a higher sense of control were less likely to report distress, including depression and anxiety, related to their SLE than those with lower perceived control . The two most common causes of depression were changes in appearance due to SLE (e.g., hair loss, weight gain) and limitations in physical activities due to symptoms such as multi-joint pain. Other factors found to increase the risk of anxiety and depression included a greater number of flares, chronic symptoms, and socioeconomic hardships (e.g., unemployment, disability leave from work) .
In general, patients with SLE report more psychiatric symptoms than general medical inpatients . A study of 326 women with SLE used the Composite International Diagnostic Interview (CIDI), the Systemic Lupus Activity Questionnaire (SLAQ), the Systemic Lupus Activity Measure (SLAM), and the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) to determine the lifetime prevalence of psychiatric disorders . The results indicated that 65% of the sample had a lifetime mood or anxiety diagnosis, and usually more than one disorder was found . The most common disorders were :
Major depressive disorder (47%)
Specific phobia (24%)
Social phobia (16%)
Obsessive-compulsive disorder (9%)
Panic disorder (8%)
Bipolar disorder (6%)
Generalized anxiety disorder (4%)
Dysthymic disorder (3%)
Only 40% of patients with SLE seek professional help for psychological disorders . This low mental health utilization rate indicates a need for outreach to this group and a need for additional research on specific, effective psychological treatments and interventions for patients with SLE. Psychological services should be flexible and timely, as patients' needs vary throughout the course of the disease. Prior to diagnosis, patients expected to live a normal life; following diagnosis, they are forced to adjust to the disease's impact on leisure activities, personal/family relationships, and employment. As a result, adjustment reaction disorder is relatively common . Quality-of-life issues and patients' perceived health status also impact adjustment to the disease. Mental health interventions should be timely, flexible, and involve a variety of psychological techniques and therapies, taking into account the severity of the disease, complications, the patient's level and impairment, and the patient's ability to cope.
Some patients will benefit from training in behavioral charting. Identifying patterns and associations between flares, stressors, pain, and physical activities can be helpful and may increase patients' perceived control and hope for the future. Exercise can increase mobility and/or flexibility by helping to build muscle tone and strength, and low-impact and moderate activities, such as stretching, walking, or aqua aerobics, may benefit management of the disease.
A combination of psychoeducational and psychotherapeutic interventions significantly improve outcomes in patients with SLE . Sustained improvements in mood, depression, anxiety, coping skills, overall mental health burden, and overall quality of life have been observed following involvement in a mix of psychoeducational sessions and group and/or individual therapy sessions. Development of coping strategies in patients with SLE can improve their ability to deal with negative emotions and the stresses associated with the disease.
SLE is a relatively rare disease, and research has often been limited to small samples. Additional large-sample research is needed in the area of SLE's impact on cognitive functioning and mental health needs. It is known that SLE is costly in terms of both healthcare utilization and impact on a patient's quality of life. Appropriately addressing the mental health issues associated with SLE through patient education programs and psychological interventions has been shown to reduce healthcare costs and lessen the complications of the disease. Patients require a targeted, sensitive, and flexible approach to health and behavioral assessment and treatments . The use of psychological and mental health services by patients with SLE is low, and research has indicated there is a high rate of unmet needs related to psychological functioning in this patient population . Effective psychoeducational and psychotherapeutic programs include stress management, coping skills, pain management, interventions for sleep disturbance, and evidence-based therapies that facilitate adjustment and reduce maladaptive behaviors .
Studies indicate that learning about one's disease process can aid individuals. In addition, it can increase the likelihood of participation in one's care and improve disease outcome . One important voluntary organization that is dedicated to providing such services is the Lupus Foundation of America (LFA). The LFA "brings patients and families together and provides beneficial information about lupus and its treatment" . The LFA has nearly 300 integrated chapters and support groups located in 23 states providing education services, referrals, health fairs, newsletters, publications, and seminars. Support is provided to lupus patients, families, and friends through the LFA organization . The foundation's website is http://www.lupus.org. To increase national recognition for lupus, May has been designated as Lupus Awareness Month.
Other resources of patient education information include:
|American Autoimmune Related Diseases Association|
|American College of Rheumatology|
|National Institute of Arthritis and Musculoskeletal and Skin Disorders|
|National Organization of Rare Disorders|
|University of San Francisco|
1. Wallace DJ. The Lupus Book: A Guide for Patients and Their Families. 5th ed. New York, NY: Oxford University Press; 2013.
2. Bachen EL, Chesney MA, Criswell L. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum. 2009;61(6):822-829.
3. Moore P, Lahita R. Neuropsychiatric Manifestations of Systemic Lupus Erythematosus. New York, NY: New York Academy of Sciences; 1997.
4. Centers for Disease Control and Prevention. Systemic Lupus Erythematosus (SLE or Lupus). Available at http://www.cdc.gov/arthritis/basics/lupus.htm. Last accessed April 6, 2015.
5. Lupus Foundation of America, Inc. What Is Lupus? Available at http://www.lupus.org/answers/entry/what-is-lupus. Last accessed April 6, 2015.
6. Scofield L, Reinlib L, Alarcón GS, Cooper GS. Employment and disability issues in systemic lupus erythematosus: a review.Arthritis Rheum. 2008;59(10):1475-1479.
7. U.S. Department of Health and Human Services, Office on Women's Health. Publications: Lupus Fact Sheet. Available at http://www.womenshealth.gov/publications/our-publications/fact-sheet/lupus.html?from=AtoZ. Last accessed April 6, 2015.
8. S.L.E. Lupus Foundation. Who Gets Lupus? Available at http://www.lupusny.org/about-lupus/who-gets-lupus. Last accessed April 6, 2015.
9. Mayo Clinic. Lupus. Available at http://www.mayoclinic.org/diseases-conditions/lupus/basics/definition/con-20019676. Last accessed April 6, 2015.
10. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Handout on Health: Systemic Lupus Erythematosus. Available at http://www.niams.nih.gov/Health_Info/Lupus/default.asp. Last accessed April 6, 2015.
11. Phillips RH. Coping with Lupus: A Practical Guide to Alleviating the Challenges of Systemic Lupus Erythematosus. 4th ed. New York, NY: Penguin Putnam; 2012.
12. Lupus Foundation of America, Inc. What Are the Laboratory Tests for Lupus? Available at http://www.lupus.org/answers/entry/lupus-tests. Last accessed April 6, 2015.
13. National Institute of Allergy and Infectious Diseases. Lupus: A Patient Care Guide for Nurses and Other Health Professionals. 3rd ed. NIH Publication No. 06-4262. Bethesda, MD: U.S. Department of Health and Human Services; 2006.
14. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
15. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277.
16. Haupt M, Millen S, Janner M, Falagan D, Fischer-Betz R, Schneider M. Improvement in coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis. 2005;64(11):1618-1623.
18. Darner GF. Self-Concept and Psychosocial Adjustment in Women with Systemic Lupus Erythematosus [dissertation]. Long Island, NY: Adelphi University; 1991.
20. Danoff-Burg S, Friedburg F. Unmet needs of patients with systemic lupus erythematosus. Behav Med. 2009;35(1):5-13.
21. Beckerman N, Auerbach C, Blanco I. Psychosocial dimensions of SLE: implications for the health care team. J Multidiscip Healthc. 2011;4:63-72.
22. Mitchell W, Thompson T. Psychiatric distress in systemic lupus erythematosus outpatients. Psychosomatics. 1990;31(3):293-300.
Mention of commercial products does not indicate endorsement.